Bridging to heart transplantation: Prostaglandin E1 versus prostacyclin versus dobutamine

Journal of Heart and Lung Transplantation

Volumn 18, Issue 4, 1999, Pages 358-366

  Stanek, Brigitte ^a   Sturm, Barbara ^a   Frey, Bernhard ^a   Hülsmann, Martin ^a   Bojic, Anda ^b   Berger, Rudolf ^a   Rödler, Suzanne ^a   Locker, Gottfried ^a   Grimm, Michael ^a   Laufer, Gnther ^a   Pacher, Richard ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; PROSTACYCLIN; PROSTAGLANDIN E1;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FORWARD HEART FAILURE; HEART TRANSPLANTATION; HUMAN; LUNG CAPILLARY PRESSURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VASODILATATION;

EID: 0032913249     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(98)00064-3     Document Type: Article

References (33)

1. Leier C.B., Webel J., Bush C.A. The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure. Circulation. 56:1977;468-472.
2. Unverferth D.V., Magorien R.D., Lewis R.P., Leier C. Longterm benefits of dobutamine in patients with congestive cardiomyopathy. Am Heart J. 100:1980;622-630.
3. Miller L.W., Merkle E.J., Jennison S.H. Outpatient use of dobutamine to support patients awaiting heart transplantation. J Heart Lung Transplant. 13:1994;S126-S129.
4. Liang C., Sherman L.G., Doherty J.U., Wellington K., Lee V.W., Hood W.B. Sustained improvement of cardiac function in patients with congestive heart failure after short time infusion of dobutamine. Circulation. 69:1984;113-119.
5. Ambulatory intermittent 6-month low-dose dobutamine infusion in severe heart failure was tested in the DICE multicenter trial. J Am Coll Cardiol. 29:1997;326A.
6. Park H.H., Young J.B., Hobbs R.E., Haas G.J., Goormastik N., Boporai R.C. The use of home inotropic therapy for patients awaiting cardiac transplant: analysis of a nationwide survey among U.S. Cardiac Transplant Centers. J Heart Lung Transplant. 17:(suppl):1998;43.
7. Dies F., Krell M.J., Whitlow P., et al. Intermittent dobutamine in ambulatory outpatients with chronic cardiac failure. Circulation. 74:(suppl. II):1986;38.
8. Krell M.J., Kline E.M., Whitlow P., et al. Intermittent, ambulatory dobutamine infusions in patients with severe congestive heart failure. Am Heart J. 112:1986;787-791.
9. O'Connor C.M., Uretsky B.F., Adams K.F., MyNulty S.E., Gheorghiade M. Intravenous dobutamine is associated with an increased risk of dying in advanced chronic heart failure: insights from the flolan international survival trial (FIRST) Circulation. 94:(supp. I):1996;I24.
10. 1 treatment of pulmonary hypertension. Am Rev Respir Dis. 136:1987;773-776.
11. Aiken J.W., Vane J.R. Intrarenal prostaglandin release attenuates the renal vasoconstrictor activity of angiotensin. J Pharmacol Exp Ther. 184:1973;678-684.
12. Hedqvist P. Basic mechanism of prostaglandin action on autonomic neurotransmission. Ann Rev Pharmacol Toxicol. 17:1977;259-265.
13. De Nucci G., Thomas R., D'Orleans-Juste P., et al. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA. 85:1988;9797-9800.
14. 1 administered intravenously to human volunteers. J Physiol Pharmacol. 42:1991;327-331.
15. 1 in humans and swine. Transplantation. 61:1996;1624-1629.
16. Dzau V.J., Packer M., Lilliy L.S., Swartz S.L., Hollenberg N.K., Williams G.H. Prostaglandins in severe congestive heart failure. Relation to activation of the renin-angiotensin system and hyponatremia. New Engl J Med. 310:1984;347-352.
17. 2 metabolite in congestive heart failure in response to captopril. Clin Cardiol. 12:1989;97-101.
18. Califf R.M., Adams K.F., McKenna, et al. A randomized controlled trial of epoprostenol therapy for severe congestive heart failure the Flolan International Randomized Survival Trial (FIRST) . Am Heart J. 134:1997;44-54.
19. 1 treatment in left ventricular heart failure. Prostaglandins Leukotrienes Essent Fatty Acids. 38:1989;177-180.
20. 1-bridge to cardiac transplantation technique, dosage, results . Eur Heart J. 18:1997;318-329.
21. 1 infusions in outpatients with severe congestive heart failure. J Heart Lung Transplant. 16:1997;556-562.
22. 1 infusion in catecholamine-dependent heart failure results of a prospective, randomized, controlled study . Crit Care Med. 22:1994;1084-1090.
23. 1 infusion insevere chronic heart failure. Prostaglandins. 53:1997;221-235.
24. Mule DJ, Gregori G, Pellegrinin P, Martinelli F, Perelli R. Identification of the patients with advanced heart failure who benefit from intermittent short-term dobutamine infusions. Circulation 1995;92:(Suppl.):I-286.
25. 1 infusion compared to prostacyclin infusion in refractory heart failure patients. Effects on hemodynamics and neurohumoral variables. J Heart Lung Transplant. 16:1997;878-881.
26. Smiley R.M., Pantuck C.B., Chadburn A., Knowles D. Down-regulation and desensitization of the β-adrenergic receptor system of human lymphocytes after cardiac surgery. Cardiovasc Anaesth. 77:1993;653-661.
27. 1 for patients who have both heart and lung failure after cardiotomy. J Cardiovasc Surg. 105:1993;1120-1121.
28. 1 infusion affect the left ventricular filling pattern of endstage dilated cardiomyopathy? A combined hemodynamic-Echo Doppler study. J Cardiovasc Pharmacol. 29:1997;188-195.
29. 1 on left ventricular systolic and diastolic performance in congestive heart failure. Circulation 1997;96(suppl. I):I-392.
30. Allen J.E. Prostaglandins in hematology. Arch Intern Med. 133:1974;86-96.
31. 1 of vascular permeability induced by vasoactive inflammatory mediators. J Immunol. 125:1980;2591-2596.
32. 1 in severe endstage chronic heart failure. Jpn Heart J. 38:1997;53-65.
33. 1 and heart transplantation. In: Körner MM, Posival H, Körfer R, eds. Thoracic organ transplantation. Amsterdam, Elsevier Science, 1994, 59-66.